🇺🇸 FDA
Patent

US 10655129

Compositions and their uses directed to huntingtin

granted A61PA61P25/00A61P25/14

Quick answer

US patent 10655129 (Compositions and their uses directed to huntingtin) held by Ionis Pharmaceuticals, Inc. expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P25/14, A61P25/28